609 Results

People

  1. Lilja
    Lilja
  2. Vickers
    Vickers
  3. Scher
    Scher
  4. Eastham
    Eastham
  5. Scardino
    Scardino
  6. Zelefsky
    Zelefsky
  7. Kattan
    Kattan
  8. Carlsson
    Carlsson
  9. Kelly
    Kelly
  10. Slovin
    Slovin

Groups

  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)
  7. Department of Medicine (143)
  8. Solid Tumor Oncology Division (138)
  9. Genitourinary Oncology Service (135)
  10. Health Outcomes Research Group (133)
  1. "prostate-specific antigen"
Formats
  1. Journal Article (570)
  2. Editorial (8)
  3. Review (8)
  4. Conference Paper (6)
  5. Guidelines (5)
  6. Meeting Abstract (4)
  7. Book Section (3)
  8. Correspondence (3)
  9. Research Letter (2)
Groups
  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)

More Groups

People
  1. Hans Lilja (135)
  2. Peter Scardino (117)
  3. Andrew Vickers (98)
  4. Howard Scher (96)
  5. James Eastham (80)
  6. Michael Zelefsky (64)

More People

Years
  1. 2025 (3)
  2. 2024 (26)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Urology (69)
  2. European Urology (47)
  3. International Journal of Radiation Oncology, Biology, Physics (40)
  4. Journal of Clinical Oncology (39)
  5. Urology (36)
  6. Clinical Cancer Research (31)

More Publications

Publishers
  1. Elsevier Science, Inc. (162)
  2. Elsevier Inc. (72)
  3. Wiley Blackwell (64)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (39)
  6. John Wiley & Sons (29)

More Publishers

Results (609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: Second-line taxane-based therapy after first-line epothilone-B analog ixahepilone (BMS-247550) therapy
    Journal Article

    Rosenberg, J. E.; Galsky, M. D.; Rohs, N. C.; Weinberg, V. K.; Oh, W. K.; Kelly, W. K.; Small, E. J.
    Cancer (2006)

    Fulltext@MSK | Save
  • PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis
    Journal Article

    Ray, M. E.; Thames, H. D.; Levy, L. B.; Horwitz, E. M.; Kupelian, P. A.; Martinez, A. A.; Michalski, J. M.; Pisansky, T. M.; Shipley, W. U.; Zelefsky, M. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save
  • Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Journal Article

    Ray, M. E.; Levy, L. B.; Horwitz, E. M.; Kupelian, P. A.; Martinez, A. A.; Michalski, J. M.; Pisansky, T. M.; Zelefsky, M. J.; Zietman, A. L.; Kuban, D. A.
    Urology (2006)

    Fulltext@MSK | Save
  • Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum
    Journal Article

    Pilronen, T.; Haese, A.; Huland, H.; Steuber, T.; Christensen, I. J.; Brünner, N.; Danø, K.; Høyer-Hansen, G.; Lilja, H.
    Clinical Chemistry (2006)

    Fulltext@MSK | Save
  • Comparison of biochemical failure definitions for permanent prostate brachytherapy
    Journal Article

    Kuban, D. A.; Levy, L. B.; Potters, L.; Beyer, D. C.; Blasko, J. C.; Moran, B. J.; Ciezki, J. P.; Zietman, A. L.; Zelefsky, M. J.; Pisansky, T. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save
  • Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: A multiinstitutional pooled analysis
    Journal Article

    Horwitz, E. M.; Levy, L. B.; Thames, H. D.; Kupelian, P. A.; Martinez, A. A.; Michalski, J. M.; Pisansky, T. M.; Sandler, H. M.; Shipley, W. U.; Zelefsky, M. J.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials
    Journal Article

    Fleming, M. T.; Morris, M. J.; Heller, G.; Scher, H. I.
    Nature Clinical Practice Oncology (2006)

    Fulltext@MSK | Save
  • High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry
    Journal Article

    Finnskog, D.; Järås, K.; Ressine, A.; Malm, J.; Marko-Varga, G.; Lilja, H.; Laurell, T.
    Electrophoresis (2006)

    Fulltext@MSK | Save
  • Rapid androgen cycling as treatment for patients with prostate cancer
    Journal Article

    Feltquate, D.; Nordquist, L.; Eicher, C.; Morris, M.; Smaletz, O.; Slovin, S.; Curley, T.; Wilton, A.; Fleisher, M.; Heller, G.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy
    Journal Article

    Eggener, S. E.; Roehl, K. A.; Yossepowitch, O.; Catalona, W. J.
    Journal of Urology (2006)

    Fulltext@MSK | Save